The Library
Sugar or salt (“SOS”) : a protocol for a UK multicentre randomised trial of mannitol and hypertonic saline in severe traumatic brain injury and intracranial hypertension
Tools
Tools
Tools
Rowland, M. J., Veenith, T., Scomparin, C., Wilson, M. H., Hutchinson, P .J., Kolias, A. G., Lall, Ranjit, Regan, S., Mason, James, Andrews, P. J. D., Horner, D., Naisbitt, J., Devrell, A., Malins, A., Dark, P., McAuley, D. F. and Perkins, Gavin D. (2022) Sugar or salt (“SOS”) : a protocol for a UK multicentre randomised trial of mannitol and hypertonic saline in severe traumatic brain injury and intracranial hypertension. Journal of the Intensive Care Society, 23 (2). pp. 222-232. doi:10.1177/1751143720901690 ISSN 1751-1437.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: https://doi.org/10.1177/1751143720901690
Abstract
Hyperosmolar solutions are widely used to treat raised intracranial pressure following severe traumatic brain injury. Although mannitol has historically been the most frequently administered, hypertonic saline solutions are increasingly being used. However, definitive evidence regarding their comparative effectiveness is lacking. The Sugar or Salt Trial is a UK randomised, allocation concealed open label multicentre pragmatic trial designed to determine the clinical and cost-effectiveness of hypertonic saline compared with mannitol in the management of patients with severe traumatic brain injury. Patients requiring intensive care unit admission and intracranial pressure monitoring post-traumatic brain injury will be allocated at random to receive equi-osmolar boluses of either mannitol or hypertonic saline following failure of routine first-line measures to control intracranial pressure. The primary outcome for the study will be the Extended Glasgow Outcome Scale assessed at six months after randomisation. Results will inform current clinical practice in the routine use of hyperosmolar therapy as well as assess the impact of potential side effects. Pre-planned longer term clinical and cost effectiveness analyses will further inform the use of these treatments.
| Item Type: | Journal Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||||
| SWORD Depositor: | Library Publications Router | ||||||||
| Journal or Publication Title: | Journal of the Intensive Care Society | ||||||||
| Publisher: | SAGE Publications | ||||||||
| ISSN: | 1751-1437 | ||||||||
| Official Date: | 1 May 2022 | ||||||||
| Dates: |
|
||||||||
| Volume: | 23 | ||||||||
| Number: | 2 | ||||||||
| Page Range: | pp. 222-232 | ||||||||
| DOI: | 10.1177/1751143720901690 | ||||||||
| Status: | Peer Reviewed | ||||||||
| Publication Status: | Published | ||||||||
| Access rights to Published version: | Free Access (unspecified licence, 'bronze OA') |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
